Submucosal fat accumulation in Crohn’s disease: evaluation with sonography

por Ripollés, Tomás, Martínez-Pérez, María Jesús, Paredes, José María, Vizuete, José, Martin, Gregorio, Navarro, Lidia
Publicado 2023

Real-world data on the infliximab biosimilar CT-P13 (Remsima(®)) in inflammatory bowel disease

por Huguet, Jose María, Cortés, Xavier, Bosca-Watts, Marta Maia, Aguas, Marian, Maroto, Nuria, Martí, Lidia, Amorós, Cirilo, Paredes, Jose María
Publicado 2021

Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests

por Paredes, José María, Ripollés, Tomás, Algarra, Ángela, Diaz, Rafael, Moreno, Nadia, Latorre, Patricia, Martínez, María Jesús, Llopis, Pilar, López, Antonio, Moreno-Osset, Eduardo
Publicado 2022

Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia

por Huguet, Jose María, Cortés, Xavier, Boscá-Watts, Marta Maia, Muñoz, Margarita, Maroto, Nuria, Iborra, Marisa, Hinojosa, Esther, Capilla, María, Asencio, Carmina, Amoros, Cirilo, Paredes, Jose María
Publicado 2022

Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study

por Bosca-Watts, Marta Maia, Cortes, Xavier, Iborra, Marisa, Huguet, Jose Maria, Sempere, Laura, Garcia, Gloria, Gil, Rafa, Garcia, MariFe, Muñoz, Marga, Almela, Pedro, Maroto, Nuria, Paredes, Jose Maria
Publicado 2016

Subcutaneous Infliximab [CT-P13], a True Biologic 2.0. Real Clinical Practice Multicentre Study

por Huguet, Jose M., García-Lorenzo, Victor, Martí, Lidia, Paredes, Jose María, Ramírez, Jose Joaquin, Pastor, Miguel, Ruiz, Lucia, Sanahuja, Ana, Timoneda, Pilar, Sanchís, Laura, Pérez, Gloria Alemany, Boscá-Watts, Marta Maia
Publicado 2022